04Nov 2022
A triple blind, placebo controlled, randomized controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus

A triple blind, placebo controlled, randomized controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus

To evaluate the effectiveness of betahistine in the treatment of primary tinnitus. Adult patients with primary tinnitus who had not undergone treatment for tinnitus in the last six months were included. Of 284 participants initially identified, 62 were randomized. Betahistine dihydrochloride was ineffective in the treatment of primary tinnitus in adults.

  • #ent

Like

Save

Share